CNTB CNTB

Connect Biopharma Share Price

0.9195
0.015 (1.66%)
Upgrade to Real-Time
Regular Market
0.9195
Volume 192,730
Bid Price 0.91
Ask Price 0.9195
News -
Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
$52.04
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
$67.09
Level 1 Starter
Monthly Subscription
for only
$15.87
VAT not included
Company Name Stock Ticker Symbol Market Type
Connect Biopharma Holdings Inc CNTB NASDAQ Depository Receipt
  Price Change Change Percent Stock Price Last Traded
0.015 1.66% 0.9195 15:21:02
Open Price Low Price High Price Close Price Prev Close
0.8884 0.86 0.95 0.9045
Trades Volume VWAP Dollar Volume Avg Volume
984 192,730  0.8895479  171,443 -
Last Trade Time Type Quantity Stock Price Currency
15:21:02 100  0.9195 USD

Period:

Draw Mode:

Connect Biopharma Holdings Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
 50.59M 55.02M 55.02M  -  - -3.93 -0.20
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
-  - - - -

more financials information »

News Connect Biopharma

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

CNTB Historical

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week0.000.000.000.0000.000.0%
1 Month0.000.000.000.0000.000.0%
3 Months0.000.000.000.0000.000.0%
6 Months0.000.000.000.0000.000.0%
1 Year0.000.000.000.0000.000.0%
3 Years0.000.000.000.0000.000.0%
5 Years0.000.000.000.0000.000.0%

Connect Biopharma Holdings Ltd is a clinical-stage company focused on the discovery and development of next-generation immune modulators for the treatment of serious autoimmune diseases and inflammation. It has leveraged its expertise in the biology of T cell modulation to build a portfolio of drug candidates consisting of small molecules and antibodies targeting critical pathways of inflammation. Its pipeline includes CBP-201, CBP-307, CBP-174, and CBP-233.


Your Recent History
NASDAQ
CNTB
Connect Bi..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.